Insider Trading activities of Surmodics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Surmodics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Surmodics Inc since year 2005. Table 2 shows the detailed insider transactions of Surmodics Inc since 2005. The reporting company's ticker symbol is SRDX. The reporting company's CIK number is 924717.
The total value of stock buying since 2005 is $176,725.
The total value of stock sales since 2005 is $18,353,851.
The total value of stock option exercises since 2005 is $9,462,486.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Surmodics Inc (SRDX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 0 $0 1,801 $49,591 0 $0
2017-08 0 $0 5,000 $128,750 0 $0
2017-07 0 $0 5,000 $140,160 0 $0
2017-06 0 $0 4,928 $123,572 0 $0
2017-04 0 $0 584 $14,600 0 $0
2017-03 0 $0 1,000 $24,725 0 $0
2017-01 0 $0 5,000 $125,250 0 $0
2016-12 0 $0 9,164 $229,583 0 $0
2016-11 0 $0 5,500 $139,125 0 $0
2016-10 0 $0 5,000 $147,770 0 $0
2016-09 0 $0 1,000 $28,741 0 $0
2016-08 0 $0 23,984 $670,657 292,573 $4,280,416
2016-06 0 $0 2,816 $65,889 0 $0
2016-05 0 $0 3,331 $74,799 16,528 $152,884
2016-03 0 $0 11,291 $208,242 0 $0
2015-12 0 $0 1,000 $21,178 0 $0
2015-09 0 $0 1,000 $23,573 0 $0
2015-08 0 $0 10,000 $261,620 0 $0
2015-06 0 $0 1,000 $23,838 0 $0
2015-05 0 $0 18,955 $472,797 13,115 $141,969
2015-03 0 $0 1,000 $24,406 23,024 $277,669
2014-12 0 $0 6,083 $132,531 0 $0
2014-11 0 $0 10,330 $217,167 10,330 $95,552
2014-09 0 $0 1,000 $20,132 0 $0
2014-05 1,500 $30,535 1,000 $21,425 0 $0
2014-04 0 $0 0 $0 15,000 $327,300
2014-03 0 $0 0 $0 5,400 $117,828
2013-12 0 $0 16,236 $372,648 33,978 $367,811
2013-05 0 $0 1,693 $44,949 1,693 $21,230
2013-03 0 $0 380 $10,005 0 $0
2012-08 0 $0 337,760 $5,981,214 0 $0
2010-12 500 $5,505 0 $0 0 $0
2010-03 0 $0 0 $0 10,000 $140,630
2009-11 0 $0 50,343 $1,191,801 0 $0
2009-10 0 $0 5,000 $148,750 0 $0
2009-05 0 $0 8,980 $182,383 0 $0
2009-02 3,125 $59,598 8,000 $143,382 6,000 $39,372
2008-11 0 $0 600 $13,406 0 $0
2008-07 100 $4,185 0 $0 0 $0
2008-05 0 $0 1,838 $80,660 2,500 $87,125
2008-04 0 $0 2,000 $89,750 0 $0
2007-08 0 $0 80,378 $3,944,276 67,100 $1,722,157
2007-07 0 $0 0 $0 10,000 $25,000
2006-11 0 $0 17,097 $578,049 14,000 $299,040
2006-10 0 $0 0 $0 42,280 $1,109,723
2006-09 0 $0 0 $0 30,000 $241,859
2006-07 0 $0 48,324 $1,770,857 0 $0
2006-02 0 $0 2,000 $80,000 0 $0
2005-12 0 $0 0 $0 900 $14,921
2005-07 2,000 $76,902 0 $0 0 $0
2005-05 0 $0 9,000 $331,600 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Surmodics Inc insiders (SRDX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-15 Olson Charles W (Senior VP & GM, Med Dev) Sale 801 27.85 22,307
2017-09-11 Stich Joseph J. (VP and GM, IVD) Sale 1,000 27.28 27,284
2017-08-07 Maharaj Gary R (President & CEO) Sale 5,000 25.75 128,750
2017-07-03 Maharaj Gary R (President & CEO) Sale 5,000 28.03 140,160
2017-06-16 Phillips Bryan K (SVP, Gen Counsel & Secretary) Sale 1,226 24.85 30,469
2017-06-09 Stich Joseph J. (VP and GM, IVD) Sale 1,000 25.31 25,313
2017-06-05 Maharaj Gary R (President & CEO) Sale 2,702 25.09 67,790
2017-04-03 Maharaj Gary R (President & CEO) Sale 584 25.00 14,600
2017-03-06 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 24.73 24,725
2017-01-03 Maharaj Gary R (President & CEO) Sale 5,000 25.05 125,250
2016-12-22 Olson Charles W (Senior VP & GM, Med Dev) Sale 1,201 26.00 31,226
2016-12-08 Olson Charles W (Senior VP & GM, Med Dev) Sale 3,699 26.02 96,244
2016-12-05 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 2,000 23.97 47,932
2016-12-02 Phillips Bryan K (SVP, Gen Counsel & Secretary) Sale 1,264 23.91 30,215
2016-11-25 Olson Charles W (Senior VP & GM, Med Dev) Sale 200 26.05 5,210
2016-11-23 Olson Charles W (Senior VP & GM, Med Dev) Sale 300 26.00 7,800
2016-11-07 Maharaj Gary R (President & CEO) Sale 5,000 25.22 126,115
2016-10-03 Maharaj Gary R (President & CEO) Sale 5,000 29.55 147,770
2016-09-06 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 28.74 28,741
2016-08-25 Bedoya Jose H (Director) Option Ex 10,000 22.35 223,500
2016-08-23 Maharaj Gary R (President & CEO) Option Ex 130,587 12.01 1,567,696
2016-08-22 Stich Joseph J. (VP, Bus Ops & GM, IVD) Option Ex 27,548 9.25 254,819
2016-08-17 Olson Charles W (Senior VP & GM, Med Dev) Sale 4,025 28.77 115,811
2016-08-16 Olson Charles W (Senior VP & GM, Med Dev) Sale 5,911 29.10 171,998
2016-08-15 Knight Susan E (Director) Sale 1,548 28.64 44,336
2016-08-12 Olson Charles W (Senior VP & GM, Med Dev) Option Ex 30,991 9.25 286,666
2016-08-09 Olson Charles W (Senior VP & GM, Med Dev) Option Ex 5,783 24.30 140,526
2016-08-03 Stich Joseph J. (VP, Bus Ops & GM, IVD) Option Ex 20,000 22.11 442,200
2016-08-01 Arens Timothy J. (VP-Corporate Dev. and Strategy) Option Ex 28,913 15.32 442,860
2016-08-01 Phillips Bryan K (SVP, Gen Counsel & Secretary) Option Ex 16,251 24.30 394,899
2016-08-01 Olson Charles W (Senior VP & GM, Med Dev) Sale 12,500 27.08 338,512
2016-08-01 Olson Charles W (Senior VP & GM, Med Dev) Option Ex 12,500 24.30 303,750
2016-08-01 Knight Susan E (Director) Option Ex 10,000 22.35 223,500
2016-06-14 Phillips Bryan K (SVP, Gen Counsel & Secretary) Sale 1,816 23.44 42,561
2016-06-10 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 23.33 23,328
2016-05-31 Knight Susan E (Director) Sale 2,330 22.35 52,066
2016-05-27 Knight Susan E (Director) Sale 1,001 22.71 22,733
2016-05-16 Knight Susan E (Director) Option Ex 16,528 9.25 152,884
2016-03-04 Arens Timothy J. (VP-Corporate Dev. and Strategy) Sale 10,291 18.43 189,611
2016-03-04 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 18.63 18,631
2015-12-04 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 21.18 21,178
2015-09-04 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 23.57 23,573
2015-08-05 Olson Charles W (Senior VP & GM, Med Dev) Sale 10,000 26.16 261,620
2015-06-05 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 23.84 23,838
2015-05-22 Phillips Bryan K (SVP, Gen Counsel & Secretary) Sale 7,293 25.25 184,140
2015-05-21 Phillips Bryan K (SVP, Gen Counsel & Secretary) Option Ex 13,115 10.82 141,969
2015-05-11 Dantzker David (Director) Sale 11,662 24.75 288,657
2015-03-03 Dantzker David (Director) Option Ex 23,024 12.06 277,669
2015-03-02 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 24.41 24,406
2014-12-29 Olson Charles W (Senior VP & GM, Med Dev) Sale 1,718 22.60 38,826
2014-12-08 Olson Charles W (Senior VP & GM, Med Dev) Sale 3,365 21.66 72,885
2014-12-01 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 20.82 20,820
2014-11-19 Arens Timothy J. (VP-Corporate Dev. and Strategy) Sale 10,330 21.02 217,167
2014-11-19 Arens Timothy J. (VP-Corporate Dev. and Strategy) Option Ex 10,330 9.25 95,552
2014-09-02 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 20.13 20,132
2014-05-30 Stich Joseph J. (VP, Bus Ops & GM, IVD) Sale 1,000 21.43 21,425
2014-05-08 Knight Susan E (Director) Buy 1,500 20.36 30,535
2014-04-29 Bedoya Jose H (Director) Option Ex 8,000 21.82 174,560
2014-04-04 Fischer Gerald B (Director) Option Ex 7,000 21.82 152,740
2014-03-01 Benson John W (Director) Option Ex 5,400 21.82 117,828
2013-12-04 Phillips Bryan K (SVP, Gen Counsel & Secretary) Sale 16,236 22.95 372,648
2013-12-03 Phillips Bryan K (SVP, Gen Counsel & Secretary) Option Ex 33,978 10.82 367,811
2013-05-15 Lehman Mark A. (Corporate Controller) Sale 1,693 26.55 44,949
2013-05-15 Lehman Mark A. (Corporate Controller) Option Ex 1,693 12.54 21,230
2013-03-05 Olson Charles W (Senior VP & GM, Med Dev) Sale 380 26.33 10,005
2012-08-14 Starboard Value & Opportunity Master Fund Ltd Sale 61,700 17.63 1,087,585
2012-08-13 Starboard Value & Opportunity Master Fund Ltd Sale 18,500 17.58 325,248
2012-08-10 Starboard Value & Opportunity Master Fund Ltd Sale 33,360 17.60 587,035
2012-08-09 Starboard Value & Opportunity Master Fund Ltd Sale 181,000 17.77 3,216,188
2012-08-08 Starboard Value & Opportunity Master Fund Ltd Sale 43,200 17.71 765,158
2010-12-15 Dantzker David Buy 500 11.01 5,505
2010-03-09 Meslow John A (Director) Option Ex 10,000 14.06 140,630
2009-11-30 Lopez Paul A (VP, President - Ophthamology) Sale 5,000 22.23 111,150
2009-11-20 Shoup Michael J (VP of Qual, Reg & Clinical) Sale 3,500 22.91 80,202
2009-11-17 Anderson Aron B (VP & Chief Scientific Officer) Sale 4,320 23.43 101,217
2009-11-16 Phillips Bryan K (VP, Gen Counsel & Secretary) Sale 1,527 23.96 36,586
2009-11-16 Olson Charles W (VP & Gen Mgr - Cardiovascular) Sale 10,996 23.85 262,221
2009-11-09 Lopez Paul A (VP, President - Ophthamology) Sale 25,000 24.02 600,425
2009-10-06 Ankeny Philip D (Senior VP & CFO) Sale 5,000 29.75 148,750
2009-05-19 Olson Charles W (VP & Gen Mgr - Cardiovascular) Sale 8,980 20.31 182,383
2009-02-27 Lopez Paul A (VP & President - Ophtalmology) Sale 3,000 17.80 53,400
2009-02-26 Lopez Paul A (VP & President - Ophtalmology) Sale 3,000 17.97 53,910
2009-02-25 Duran Lise W (VP of Research) Sale 2,000 18.04 36,072
2009-02-12 Keller Kenneth H (Director) Option Ex 6,000 6.56 39,372
2009-02-10 Buhrmaster Robert C (Director) Buy 2,625 19.09 50,111
2009-02-09 Knight Susan E (Director) Buy 500 18.98 9,487
2008-11-28 Astry Douglas P (Gen Mgr, In Vitro Technologies) Sale 600 22.34 13,406
2008-07-31 Lehman Mark A. (Treasurer) Buy 100 41.85 4,185
2008-05-09 Anderson Aron B (VP & Chief Scientific Officer) Sale 1,838 43.88 80,660
2008-05-09 Anderson Aron B (VP & Chief Scientific Officer) Option Ex 2,500 34.85 87,125
2008-04-30 Duran Lise W (VP & Gen Mgr, Regen Tech) Sale 2,000 44.88 89,750
2007-08-29 Lopez Paul A (Vice President) Sale 20,000 48.35 967,744
2007-08-29 Lopez Paul A (Vice President) Option Ex 20,000 38.07 761,400
2007-08-27 Anderson Aron B (VP & Chief Scientific Officer) Sale 3,600 48.00 172,800
2007-08-22 Keller Kenneth H (Director) Option Ex 10,000 2.50 25,000
2007-08-20 Anderson Aron B (VP & Chief Scientific Officer) Sale 3,500 50.00 175,000
2007-08-20 Anderson Aron B (VP & Chief Scientific Officer) Option Ex 3,500 25.09 87,829
2007-08-17 Duran Lise W (VP & Genl Mgr-Regen Tech) Option Ex 16,000 25.09 401,504
2007-08-16 Olson Charles W (VP & Genl Mgr-Hydroph Tech) Sale 10,340 50.30 520,060
2007-08-16 Keough Steven J (Sr VP/GM Orthop/Chf IP Cnsl) Sale 17,600 49.56 872,273
2007-08-16 Keough Steven J (Sr VP/GM Orthop/Chf IP Cnsl) Option Ex 17,600 25.36 446,424
2007-08-16 Keller Kenneth H (Director) Sale 10,000 49.24 490,906
2007-07-30 Keller Kenneth H (Director) Option Ex 10,000 2.50 25,000
2006-11-30 Keough Steven J (Sr VP/Chf IP Cnsl/GM-New Vntrs) Sale 17,097 33.81 578,049
2006-11-30 Keough Steven J (Sr VP/Chf IP Cnsl/GM-New Vntrs) Option Ex 14,000 21.36 299,040
2006-10-26 Olseth Dale R (Director) Option Ex 42,280 26.25 1,109,723
2006-09-12 Olseth Dale R (Director) Option Ex 30,000 8.06 241,859
2006-07-25 Koch David A (Director) Sale 27,612 36.88 1,013,834
2006-02-27 Duran Lise W (VP & Genl Mgr-Regen Tech) Sale 2,000 40.00 80,000
2005-12-21 Anderson Aron B (VP & Chief Scientifi) Option Ex 900 16.58 14,921
2005-07-26 Olseth Dale R (Chairman and CEO) Buy 2,000 38.45 76,902
2005-05-09 Duran Lise W (Genl Mgr-Regen Tech) Sale 1,000 40.00 40,000
2005-05-02 Duran Lise W (Genl Mgr-Regen Tech) Sale 8,000 36.45 291,600

Insider trading activities including stock purchases, stock sales, and option exercises of SRDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Surmodics Inc (symbol SRDX, CIK number 924717) see the Securities and Exchange Commission (SEC) website.